Cigna stock forecast
Cigna's weighted share price rises from $303.61 in October 2027 to $368.15 in October 2029, including dividends. The forecast hinges on whether Signature preserves pharmacy economics while cash generation supports each share.
Where could Cigna's shares be by 2029?
Cigna’s weighted share price rises from $303.61 in October 2027 to $368.15 in October 2029, including dividends. That means a modest 3% return after one year, followed by 15% after two years and 29% after three years. The 2029 outcomes span $260.14 in the bear case to $486.53 in the bull case, against today’s $301.27 price.
The bear case requires Signature to win clients through concessions while PBM earnings remain pressured. Slower growth and weaker cash conversion restrict buybacks, increase concern about debt and contract economics, and compress the multiple. It produces $284.28 in October 2027 and $260.14 in October 2029, including dividends. Its 28% probability sits above the 25% estimates from the earnings and dividend specialists and near the multiple specialist’s 30%, because the pressure is already visible but does not require an earnings collapse.
| Case | Probability | October 2027 | October 2028 | October 2029 |
|---|---|---|---|---|
| Bear | 28 % | 284.28 (-4 %) | 272.36 (-6 %) | 260.14 (-8 %) |
| Base | 52 % | 305.38 (+4 %) | 341.05 (+18 %) | 380.78 (+34 %) |
| Bull | 20 % | 326.11 (+11 %) | 398.83 (+37 %) | 486.53 (+69 %) |
| Weighted | 100 % | 303.61 (+3 %) | 333.37 (+15 %) | 368.15 (+29 %) |
What this means. The weighted row is the probability-based average of the three cases, not a promise that the shares will reach that price.
What has to go right for Cigna, and what could go wrong?
The bear case reaches only $9,195 million because PBM pressure and weak cash conversion reduce growth to 2%. Pharmacy Benefit Services income fell 27% in the latest quarter, while first-half operating cash flow was only $710 million. The bull case reaches $11,181 million by applying the 14% high end, assuming Signature scales without lasting margin damage and specialty earnings and savings strengthen. The historical increase in adjusted EPS from $20.47 in 2021 to $29.84 in 2025 supports continued growth, but not the bull outcome by itself.
Persistent concessions or weaker cash conversion justify compression. Successful Signature adoption, specialty growth and modernization savings could instead improve confidence in earnings quality and support expansion.
How much cash does Cigna really make?
After about $1.2 billion of capital expenditure, roughly $8.4 billion remained before acquisitions, distributions and debt repayment. Cigna does not separately identify the minimum maintenance portion of that spending.
What does an investor pay for Cigna today?
| Today (Oct 16, 2026) | |
|---|---|
| Share price | 301.27 |
| Market value (calculated) | 79,607.73 |
| P/E, last 12 months (calculated) | 12.5x |
| P/E on core earnings, last 12 months (calculated) | 9.6x |
| P/E, next 12 months (calculated) | 9.0x |
| Price to book (calculated) | 1.9x |
What this means. The price-to-earnings figure based on core earnings uses the insurer’s own adjusted measure of ongoing profit, so it can differ from the figure based on reported profit.